---
category: news
title: "Who can make Gilead's coronavirus drug, licence free?"
excerpt: "Gilead Sciences Inc is in talks with chemical and drug makers to produce its experimental drug remdesivir, a potential coronavirus treatment, for Europe, Asia and the developing world, the firm has said."
publishedDateTime: 2020-05-06T10:57:00Z
webUrl: "https://www.reuters.com/article/us-health-coronavirus-gilead-sciences-ex-idUSKBN22I1GP"
ampWebUrl: "https://mobile.reuters.com/article/amp/idUSKBN22I1GP"
cdnAmpWebUrl: "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSKBN22I1GP"
type: article
quality: 105
heat: 115
published: true

provider:
  name: Reuters
  domain: reuters.com
  images:
    - url: "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - Treatment
  - Coronavirus

images:
  - url: "https://s2.reutersmedia.net/resources/r/?m=02&d=20200506&t=2&i=1517641619&w=&fh=545px&fw=&ll=&pl=&sq=&r=LYNXMPEG450VC"
    width: 817
    height: 545
    title: "Who can make Gilead's coronavirus drug, licence free?"

related:
  - title: "EXPLAINER-Who can make Gilead's coronavirus drug, licence free?"
    excerpt: "Gilead Sciences Inc GILD.O is in talks with chemical and drug makers to produce its experimental drug remdesivir, a potential coronavirus treatment, for Europe, Asia and the developing world, the firm has said."
    publishedDateTime: 2020-05-06T11:01:00Z
    webUrl: "https://www.nasdaq.com/articles/explainer-who-can-make-gileads-coronavirus-drug-licence-free-2020-05-06"
    ampWebUrl: "https://www.nasdaq.com/articles/explainer-who-can-make-gileads-coronavirus-drug-licence-free-2020-05-06?amp"
    cdnAmpWebUrl: "https://www-nasdaq-com.cdn.ampproject.org/c/s/www.nasdaq.com/articles/explainer-who-can-make-gileads-coronavirus-drug-licence-free-2020-05-06?amp"
    type: article
    provider:
      name: Nasdaq
      domain: nasdaq.com
    quality: 85

secured: "MBIUoA2PBmdWoLUrHWIjkD0ChC3vESIbuWiDD32PS+A+Ck2utvNXhaO/JbAwXrS8Q3wjixv+rSIrIFmN/M4L7RVgf2FoJRvllbMp7eUY/hXdwgI+6rNGslQji4JDLrt+t/CPrYtvKUwHel/bg+kYIkDoZzswor2TyfhR+uP0N1FdQw72xEHSeplFVY3zJBC4xJ2NxptKHiQ3pMeG3iUDtX5FSwQ2mEbeK0wYEURb6EPeq1xAIAncaqgRoS6NseEuuqn0Gq75ESxv4T22BdfiDZOjp3CUZqqiep4ay6t+NF8n86a4+hQ3frctUzjm2UEbMNLlRCieKdCwH5y240bipO1FJzIQ581nghF7AhlfrV4LGhLxPx7e2s2UZJwZpclLKdf1Q4ur8podv/Ufd9NEUv/0+OcJJCxpPBvyb+mIbmTKixOLRN0ODUbrB14E9gjYQeJVureVVAXIEm9Vo3UhXAX+gHAowqEZ6eLzluJo4J0=;5lt1wtip3w51NrrYFxWP1Q=="
---

